Anbc, Inc. (SYUP)

Market Cap	23.88K -99.4%
Revenue (ttm)	50.95K -83.7%
Net Income	-382.25K
EPS	n/a
Shares Out	79.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	925
Average Volume	33,721
Open	0.0003
Previous Close	n/a
Day's Range	0.0003 - 0.0003
52-Week Range	0.0001 - 0.0050
Beta	-6.57
RSI	41.47
Earnings Date	n/a

About Anbc, Inc.

Shanghai Yutong Pharma, Inc. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People’s Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-q...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Wei Dong
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: SYUP

Financial Performance

In 2007, Anbc, Inc.'s revenue was $50,946, a decrease of -83.70% compared to the previous year's $312,494. Losses were -$382,246, 18.2% more than in 2006.